Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril/Folic Acid for CKD Prevention in Hypertensive Patients
NCT01871740Phase 4Withdrawn
- Sponsor
- Shenzhen Ausa Pharmaceutical
- Start
- May 2008
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of folic acid in chronic kidney disease (CKD), sponsored by Shenzhen Ausa Pharmaceutical. Planned start May 2008; status: withdrawn.
02
Drugs
folic acid
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01871740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01871740.